Lexeo Therapeutics, Inc. Common Stock (LXEO)
Largest Insider Buys in Sector
LXEO Stock Price History Chart
LXEO Stock Performance
About Lexeo Therapeutics, Inc. Common Stock
Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. …
Insider Activity of Lexeo Therapeutics, Inc. Common Stock
Over the last 12 months, insiders at Lexeo Therapeutics, Inc. Common Stock have bought $104,852 and sold $133,817 worth of Lexeo Therapeutics, Inc. Common Stock stock.
On average, over the past 5 years, insiders at Lexeo Therapeutics, Inc. Common Stock have bought $5.05M and sold $133,817 worth of stock each year.
Highest buying activity among insiders over the last 12 months: CHOLMONDELEY PAULA H (director) — $629,109.
The last purchase of 15,000 shares for transaction amount of $104,852 was made by CHOLMONDELEY PAULA H (director) on 2024‑11‑25.
List of Insider Buy and Sell Transactions, Lexeo Therapeutics, Inc. Common Stock
| 2024-12-10 | Sale | Chief Executive Officer | 2,500 0.0076% | $8.20 | $20,491 | -16.03% | ||
| 2024-11-25 | director | 15,000 0.0385% | $6.99 | $104,852 | +1.52% | |||
| 2024-11-11 | Sale | Chief Executive Officer | 2,500 0.0072% | $7.82 | $19,557 | -9.69% | ||
| 2024-10-10 | Sale | Chief Executive Officer | 5,000 0.0149% | $8.10 | $40,496 | -0.57% | ||
| 2024-09-10 | Sale | Chief Executive Officer | 5,000 0.0196% | $10.65 | $53,274 | -19.95% | ||
| 2023-11-07 | 10 percent owner | 454,545 1.8373% | $11.00 | $5M | +25.53% | |||
| 2023-11-07 | 10 percent owner | 454,545 1.8373% | $11.00 | $5M | +25.53% |
Insider Historical Profitability
| CHOLMONDELEY PAULA H | director | 30627 0.0926% | $6.32 | 1 | 0 | |
| Longitude Capital Partners IV, LLC | 10 percent owner | 2567100 7.7636% | $6.32 | 1 | 0 | +25.53% |
| Omega Fund VI, L.P. | 10 percent owner | 2157623 6.5252% | $6.32 | 1 | 0 | +25.53% |